CAS No.1476776-55-2 Pharmaceutical Intermediates
introduce
Niraparib intermediates are important chemical compounds used in the synthesis of niraparib, a potent, oral poly (ADP-ribose) polymerase (PARP) inhibitor. This intermediate plays an important role in the pharmaceutical industry, especially in the development of targeted therapies for various cancers, including ovarian and breast cancer. The unique structure of niraparib intermediates enables efficient synthesis and high yields, making them an essential component in the production of this life-saving drug.
Physical and chemical properties
- Molecular formula: C16H22BrNO2
- Molecular weight: 340.26 g/mol
- Appearance: The compound is usually a white powder.
- Solubility: Soluble in organic solvents such as dimethyl sulfoxide (DMSO) and methanol, with limited solubility in water, which is beneficial for various synthetic processes.
- Melting Point: The melting point of the niraparib intermediate is approximately 150-155°C, indicating that it is stable under standard laboratory conditions.
- Chemical Stability: The compound exhibits good stability under recommended storage conditions, ensuring its effectiveness in pharmaceutical formulations.
- Essential for synthesis: As a key intermediate in the production of niraparib, it is essential for the development of effective cancer therapeutics.
- High reactivity: The chemical structure of niraparib intermediates allows for efficient reactions, thus facilitating the synthesis of niraparib in high yield.
- Quality Assurance: Niraparib intermediates are produced under strict quality control measures and comply with international pharmaceutical standards to ensure safety and efficacy.
- Cost Effective: Our integrated manufacturing and trading model enables us to offer competitive prices without compromising quality.
- Global Availability: With a strong distribution network, we ensure timely delivery of Niraparib intermediates to customers around the world.
- Synthesis of Niraparib: This compound is essential for the production of Niraparib, which is used to treat various cancers, especially those associated with BRCA mutations.
- Research and Development: Its versatility makes it a valuable compound for research laboratories engaged in drug discovery and development, particularly in oncology.
- Formulation Development: Niraparib intermediates can be used to formulate various dosage forms to improve the bioavailability and efficacy of the final product.
In conclusion,Niraparib intermediates are an important chemical component with important applications in the pharmaceutical industry. Their unique properties, coupled with our commitment to quality and reliability, make them an ideal choice for pharmaceutical manufacturers and researchers. By choosing Niraparib intermediates, you invest in a critical building block that can drive innovation in cancer treatment.



